{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:23:34Z","timestamp":1773329014159,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,11]]},"DOI":"10.7759\/cureus.105072","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:00:02Z","timestamp":1773280802000},"source":"Crossref","is-referenced-by-count":0,"title":["Transcatheter Aortic Valve Replacement Within a Structured Secondary Prevention Framework in Cardiovascular Disease"],"prefix":"10.7759","author":[{"given":"Mar\u00eda Jennifer","family":"Valle Mena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maynor Jose","family":"Lopez Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonieta","family":"Salazar Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolle","family":"Contreras Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asdrubal","family":"Ulloa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeilyn","family":"Jiron Vindas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123539","article-title":"Aortic stenosis and the evolution of cardiac damage after transcatheter aortic valve replacement","volume":"13","author":"Islas F","year":"2024","unstructured":"Islas F, O'Neill-Gonz\u00e1lez P, Jim\u00e9nez-Quevedo P, et al.. Aortic stenosis and the evolution of cardiac damage after transcatheter aortic valve replacement. J Clin Med. 2024, 13:10.3390\/jcm13123539","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.07.003","article-title":"Aortic valve disease, transcatheter aortic valve replacement, and the\u00a0heart\u00a0failure patient: a state-of-the-art review","volume":"11","author":"Okumus N","year":"2023","unstructured":"Okumus N, Abraham S, Puri R, Tang WH. Aortic valve disease, transcatheter aortic valve replacement, and the\u00a0heart\u00a0failure patient: a state-of-the-art review. JACC Heart Fail. 2023, 11:1070-83. 10.1016\/j.jchf.2023.07.003","journal-title":"JACC Heart Fail"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247625","article-title":"Coronary artery disease and severe aortic stenosis: contemporary treatment options for patients undergoing transcatheter aortic valve implantation","volume":"13","author":"Ktenopoulos N","year":"2024","unstructured":"Ktenopoulos N, Karanasos A, Katsaros O, et al.. Coronary artery disease and severe aortic stenosis: contemporary treatment options for patients undergoing transcatheter aortic valve implantation. J Clin Med. 2024, 13:7625. 10.3390\/jcm13247625","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.971762","article-title":"A 20-year journey in transcatheter aortic valve implantation: evolution to current eminence","volume":"9","author":"Kalogeropoulos AS","year":"2022","unstructured":"Kalogeropoulos AS, Redwood SR, Allen CJ, et al.. A 20-year journey in transcatheter aortic valve implantation: evolution to current eminence. Front Cardiovasc Med. 2022, 9:971762. 10.3389\/fcvm.2022.971762","journal-title":"Front Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14061844","article-title":"Transcatheter aortic valve implantation and replacement: the latest advances and prospects","volume":"14","author":"Brankovic M","year":"2025","unstructured":"Brankovic M, Sharma A. Transcatheter aortic valve implantation and replacement: the latest advances and prospects\r\n. J Clin Med. 2025, 14:10.3390\/jcm14061844","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14196761","article-title":"Redefining aortic valve replacement: the transition from open surgery to transcatheter innovation","volume":"14","author":"Lodge F","year":"2025","unstructured":"Lodge F, Soliman F, Kandula V, Tagliafierro M, Pirelli L. Redefining aortic valve replacement: the transition from open surgery to transcatheter innovation. J Clin Med. 2025, 14:10.3390\/jcm14196761","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.122.012607","article-title":"Advancing transcatheter aortic valve replacement to the frontiers of lifetime valve management: deliberations from the OBSERVANT II trial","volume":"15","author":"Tully A","year":"2022","unstructured":"Tully A, Tom S, Crepy D'Orleans C, Grubb KJ. Advancing transcatheter aortic valve replacement to the frontiers of lifetime valve management: deliberations from the OBSERVANT II trial. Circ Cardiovasc Interv. 2022, 15:e012607. 10.1161\/CIRCINTERVENTIONS.122.012607","journal-title":"Circ Cardiovasc Interv"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2020.09.040","article-title":"Outcomes of transcatheter aortic valve replacement with percutaneous coronary intervention versus surgical aortic valve replacement with coronary artery bypass grafting","volume":"137","author":"Abugroun A","year":"2020","unstructured":"Abugroun A, Osman M, Awadalla S, Klein LW. Outcomes of transcatheter aortic valve replacement with percutaneous coronary intervention versus surgical aortic valve replacement with coronary artery bypass grafting. Am J Cardiol. 2020, 137:83-8. 10.1016\/j.amjcard.2020.09.040","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2024.01.010","article-title":"TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: the transcatheter valve and vessels trial (TCW trial): design and rationale","volume":"270","author":"Kedhi E","year":"2024","unstructured":"Kedhi E, Rroku A, Hermanides RS, et al.. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: the transcatheter valve and vessels trial (TCW trial): design and rationale. Am Heart J. 2024, 270:86-94. 10.1016\/j.ahj.2024.01.010","journal-title":"Am Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.05.036","article-title":"Predicting 5-year clinical outcomes after transcatheter or surgical aortic valve replacement (a risk score from the SURTAVI Trial)","volume":"200","author":"van Bergeijk KH","year":"2023","unstructured":"van Bergeijk KH, Wykrzykowska JJ, van Mieghem NM, et al.. Predicting 5-year clinical outcomes after transcatheter or surgical aortic valve replacement (a risk score from the SURTAVI Trial). Am J Cardiol. 2023, 200:78-86. 10.1016\/j.amjcard.2023.05.036","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178163","article-title":"Shared risk factors and molecular mechanisms between aortic stenosis and atherosclerosis: a rationale for therapeutic repositioning","volume":"26","author":"Cinezan C","year":"2025","unstructured":"Cinezan C, Magureanu DC, Hiceag ML, et al.. Shared risk factors and molecular mechanisms between aortic stenosis and atherosclerosis: a rationale for therapeutic repositioning. Int J Mol Sci. 2025, 26:10.3390\/ijms26178163","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081617","article-title":"Pathophysiology, diagnosis, and treatment of patients with concomitant severe aortic stenosis and coronary artery disease: a closer look to the unresolved perplexity","volume":"10","author":"Di Gioia G","year":"2021","unstructured":"Di Gioia G, Bartunek J, Tesorio T, et al.. Pathophysiology, diagnosis, and treatment of patients with concomitant severe aortic stenosis and coronary artery disease: a closer look to the unresolved perplexity. J Clin Med. 2021, 10:10.3390\/jcm10081617","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.1798","article-title":"Progression of aortic stenosis in patients with diabetes mellitus type 2 compared with matched controls","volume":"45","author":"Kontogeorgos S","year":"2024","unstructured":"Kontogeorgos S, Rosengren A, Sandstrom T, et al.. Progression of aortic stenosis in patients with diabetes mellitus type 2 compared with matched controls. Eur Heart J. 2024, 45:10.1093\/eurheartj\/ehae666.1798","journal-title":"Eur Heart J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.1658","article-title":"Aortic valve sclerosis, stenosis, and prognosis in the general population","volume":"44","author":"Dons MF","year":"2023","unstructured":"Dons MF, Shabib A, Olsen FJ, et al.. Aortic valve sclerosis, stenosis, and prognosis in the general population. Eur Heart J. 2023, 44:10.1093\/eurheartj\/ehad655.1658","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab724.1561","article-title":"Atherosclerosis associated pathways are upregulated in stenotic aortic valves from patients with severe concomitant coronary artery disease","volume":"42","author":"Plunde O","year":"2021","unstructured":"Plunde O, Sarajlic P, Franco-Cereceda A, Back M. Atherosclerosis associated pathways are upregulated in stenotic aortic valves from patients with severe concomitant coronary artery disease. Eur Heart J. 2021, 42:10.1093\/eurheartj\/ehab724.1561","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.070502","article-title":"Aortic stenosis and coronary artery disease: decision-making between surgical and transcatheter management","volume":"150","author":"Tomii D","year":"2024","unstructured":"Tomii D, Pilgrim T, Borger MA, et al.. Aortic stenosis and coronary artery disease: decision-making between surgical and transcatheter management. Circulation. 2024, 150:2046-69. 10.1161\/CIRCULATIONAHA.124.070502","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-020-0835-1","article-title":"Degenerative severe aortic stenosis and concomitant coronary artery disease: what is changing in the era of the \u201cTranscatheter Revolution\u201d?","volume":"22","author":"Pepe M","year":"2020","unstructured":"Pepe M, Larosa C, Rosa I, et al.. Degenerative severe aortic stenosis and concomitant coronary artery disease: what is changing in the era of the \u201cTranscatheter Revolution\u201d?. Curr Atheroscler Rep. 2020, 22:17. 10.1007\/s11883-020-0835-1","journal-title":"Curr Atheroscler Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2311826","article-title":"The changing landscape of aortic-valve stenosis management","volume":"389","author":"Landmesser U","year":"2023","unstructured":"Landmesser U. The changing landscape of aortic-valve stenosis management. N Engl J Med. 2023, 389:2008-9. 10.1056\/NEJMe2311826","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-020-01281-0","article-title":"TAVI imaging: over the echocardiography","volume":"125","author":"La Grutta L","year":"2020","unstructured":"La Grutta L, Toia P, Grassedonio E, et al.. TAVI imaging: over the echocardiography. Radiol Med. 2020, 125:1148-66. 10.1007\/s11547-020-01281-0","journal-title":"Radiol Med"},{"key":"ref20","article-title":"Aortic valve area and strain measurements by cardiac MRI and transthoracic echocardiography in severe aortic stenosis with normal left ventricular function","volume":"48","author":"Rezaeian N","year":"2023","unstructured":"Rezaeian N, Hosseini L, Samiei N, et al.. Aortic valve area and strain measurements by cardiac MRI and transthoracic echocardiography in severe aortic stenosis with normal left ventricular function. Iran J Med Sci. 2023, 48:370-8.","journal-title":"Iran J Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.05.046","article-title":"Daycase transcatheter aortic valve replacement: preliminary experience","volume":"13","author":"Williams PD","year":"2020","unstructured":"Williams PD, Vijayan S, McCalmont G, Muir D. Daycase transcatheter aortic valve replacement: preliminary experience. JACC Cardiovasc Interv. 2020, 13:1838-41. 10.1016\/j.jcin.2020.05.046","journal-title":"JACC Cardiovasc Interv"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082104","article-title":"Strategies for facilitating totally percutaneous transfemoral TAVR procedures","volume":"11","author":"Eitan A","year":"2022","unstructured":"Eitan A, Sliman H, Shiran A, Jaffe R. Strategies for facilitating totally percutaneous transfemoral TAVR procedures. J Clin Med. 2022, 11:10.3390\/jcm11082104","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2023.07.109","article-title":"Early safety and performance of the premounted dry-pericardium Vienna self-expandable transcatheter aortic valve system: 30-day outcomes of the first-in-human VIVA feasibility study","volume":"204","author":"Briedis K","year":"2023","unstructured":"Briedis K, Aldujeli A, Zaliunas R, Benetis R. Early safety and performance of the premounted dry-pericardium Vienna self-expandable transcatheter aortic valve system: 30-day outcomes of the first-in-human VIVA feasibility study. Am J Cardiol. 2023, 204:302-11. 10.1016\/j.amjcard.2023.07.109","journal-title":"Am J Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12247748","article-title":"Current usefulness of transesophageal echocardiography in patients undergoing transcatheter aortic valve replacement","volume":"12","author":"de Agustin JA","year":"2023","unstructured":"de Agustin JA, Pozo Osinalde E, Olmos C, et al.. Current usefulness of transesophageal echocardiography in patients undergoing transcatheter aortic valve replacement. J Clin Med. 2023, 12:10.3390\/jcm12247748","journal-title":"J Clin Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.29117","article-title":"Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program","volume":"97","author":"Costa G","year":"2021","unstructured":"Costa G, Bieliauskas G, Fukutomi M, Ihlemann N, S\u00f8ndergaard L, De Backer O. Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program. Catheter Cardiovasc Interv. 2021, 97:E418-24. 10.1002\/ccd.29117","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071344","article-title":"Comparison between surgical access and percutaneous closure device in 787 patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Eckner D","year":"2021","unstructured":"Eckner D, Pollari F, Santarpino G, et al.. Comparison between surgical access and percutaneous closure device in 787 patients undergoing transcatheter aortic valve replacement. J Clin Med. 2021, 10:10.3390\/jcm10071344","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13154471","article-title":"SURgical vs. PERcutaneous ACCESS in transfemoral transcatheter aortic valve implantation (SU-PER-ACCESS Study)","volume":"13","author":"Cammardella AG","year":"2024","unstructured":"Cammardella AG, Russo M, Di Mauro M, et al.. SURgical vs. PERcutaneous ACCESS in transfemoral transcatheter aortic valve implantation (SU-PER-ACCESS Study). J Clin Med. 2024, 13:10.3390\/jcm13154471","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102478","article-title":"Complications in transcatheter aortic valve replacement: a comprehensive analysis and management strategies","volume":"49","author":"Zou Q","year":"2024","unstructured":"Zou Q, Wei Z, Sun S. Complications in transcatheter aortic valve replacement: a comprehensive analysis and management strategies. Curr Probl Cardiol. 2024, 49:102478. 10.1016\/j.cpcardiol.2024.102478","journal-title":"Curr Probl Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.4449","article-title":"Outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: a review of a disruptive technology in aortic valve surgery","volume":"155","author":"Boskovski MT","year":"2020","unstructured":"Boskovski MT, Nguyen TC, McCabe JM, Kaneko T. Outcomes of transcatheter aortic valve replacement in patients with severe aortic stenosis: a review of a disruptive technology in aortic valve surgery. JAMA Surg. 2020, 155:69-77. 10.1001\/jamasurg.2019.4449","journal-title":"JAMA Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9020035","article-title":"The effect of TAVR on left ventricular and left atrial mechanics in patients with aortic stenosis","volume":"9","author":"Anastasius M","year":"2022","unstructured":"Anastasius M, Ro R, Gavalas M, et al.. The effect of TAVR on left ventricular and left atrial mechanics in patients with aortic stenosis. J Cardiovasc Dev Dis. 2022, 9:10.3390\/jcdd9020035","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.2464","article-title":"Discordance between symptomatic response and changes in cardiac structure and function one year after transcatheter aortic valve implantation","volume":"1","author":"Venema C","year":"2024","unstructured":"Venema C, Van Bergeijk K, Plekkenpol L, et al.. Discordance between symptomatic response and changes in cardiac structure and function one year after transcatheter aortic valve implantation. Eur Heart J. 2024, 1:45. 10.1093\/eurheartj\/ehae666.2464","journal-title":"Eur Heart J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.04.060","article-title":"Prognostic implications of change in left ventricular ejection fraction after transcatheter aortic valve implantation","volume":"177","author":"Kuneman JH","year":"2022","unstructured":"Kuneman JH, Butcher SC, Singh GK, et al.. Prognostic implications of change in left ventricular ejection fraction after transcatheter aortic valve implantation. Am J Cardiol. 2022, 177:90-9. 10.1016\/j.amjcard.2022.04.060","journal-title":"Am J Cardiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1259188","article-title":"Clinical impact of aortic valve replacement in patients with moderate mixed aortic valve disease","volume":"10","author":"Onishi H","year":"2023","unstructured":"Onishi H, Izumo M, Ouchi T, Yuki H, Naganuma T, Nakao T, Nakamura S. Clinical impact of aortic valve replacement in patients with moderate mixed aortic valve disease. Front Cardiovasc Med. 2023, 10:1259188. 10.3389\/fcvm.2023.1259188","journal-title":"Front Cardiovasc Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd12010029","article-title":"Rapid improvement in cardiac damage predicts better prognosis after transcatheter aortic valve replacement","volume":"12","author":"Lee HW","year":"2025","unstructured":"Lee HW, Chin CH, Chou PC, Chang CH, Tsai CL, Huang CH. Rapid improvement in cardiac damage predicts better prognosis after transcatheter aortic valve replacement. J Cardiovasc Dev Dis. 2025, 12:10.3390\/jcdd12010029","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046693","article-title":"Cardiac and vascular changes after transcatheter or surgical aortic valve replacement in low-risk aortic stenosis","volume":"141","author":"Delgado V","year":"2020","unstructured":"Delgado V, Kumbhani DJ. Cardiac and vascular changes after transcatheter or surgical aortic valve replacement in low-risk aortic stenosis. Circulation. 2020, 141:1538-40. 10.1161\/CIRCULATIONAHA.120.046693","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-319767","article-title":"Care of the patient after valve intervention","volume":"108","author":"Millar LM","year":"2022","unstructured":"Millar LM, Lloyd G, Bhattacharyya S. Care of the patient after valve intervention. Heart. 2022, 108:1516-23. 10.1136\/heartjnl-2021-319767","journal-title":"Heart"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082190","article-title":"Antithrombotic therapy following transcatheter aortic valve replacement","volume":"11","author":"Granger C","year":"2022","unstructured":"Granger C, Guedeney P, Collet JP. Antithrombotic therapy following transcatheter aortic valve replacement. J Clin Med. 2022, 11:2190. 10.3390\/jcm11082190","journal-title":"J Clin Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2022.10.010","article-title":"No antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry","volume":"16","author":"Kobari Y","year":"2023","unstructured":"Kobari Y, Inohara T, Tsuruta H, et al.. No antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry. JACC Cardiovasc Interv. 2023, 16:79-91. 10.1016\/j.jcin.2022.10.010","journal-title":"JACC Cardiovasc Interv"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno D","year":"2021","unstructured":"Capodanno D, Collet JP, Dangas G, Montalescot G, Ten Berg JM, Windecker S, Angiolillo DJ. Antithrombotic therapy after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2021, 14:1688-703. 10.1016\/j.jcin.2021.06.020","journal-title":"JACC Cardiovasc Interv"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02689-w","article-title":"Long-term echocardiographic findings after TAVR: 5-year follow-up in 400 consecutive patients","volume":"16","author":"Stolcova M","year":"2021","unstructured":"Stolcova M, Meucci F, Moretti C, et al.. Long-term echocardiographic findings after TAVR: 5-year follow-up in 400 consecutive patients. Intern Emerg Med. 2021, 16:1873-82. 10.1007\/s11739-021-02689-w","journal-title":"Intern Emerg Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.31677","article-title":"Outcomes beyond 10 years after transcatheter aortic valve implantation in high\u2010risk patients with severe aortic valve stenosis","volume":"106","author":"Dietze E","year":"2025","unstructured":"Dietze E, Richter I, Dumpies O, et al.. Outcomes beyond 10 years after transcatheter aortic valve implantation in high\u2010risk patients with severe aortic valve stenosis. Catheter Cardiovasc Interv. 2025, 106:1301-9. 10.1002\/ccd.31677","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2022.02.014","article-title":"5-year follow-up from the PARTNER 2 Aortic Valve-in-Valve Registry for degenerated aortic surgical\u00a0bioprostheses","volume":"15","author":"Hahn RT","year":"2022","unstructured":"Hahn RT, Webb J, Pibarot P, et al.. 5-year follow-up from the PARTNER 2 Aortic Valve-in-Valve Registry for degenerated aortic surgical\u00a0bioprostheses. JACC Cardiovasc Interv. 2022, 15:698-708. 10.1016\/j.jcin.2022.02.014","journal-title":"JACC Cardiovasc Interv"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2023.09.047","article-title":"Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis","volume":"168","author":"Beaver T","year":"2024","unstructured":"Beaver T, Bavaria JE, Griffith B, et al.. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. J Thorac Cardiovasc Surg. 2024, 168:781-91. 10.1016\/j.jtcvs.2023.09.047","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/466110-transcatheter-aortic-valve-replacement-within-a-structured-secondary-prevention-framework-in-cardiovascular-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:00:03Z","timestamp":1773280803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/466110-transcatheter-aortic-valve-replacement-within-a-structured-secondary-prevention-framework-in-cardiovascular-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.105072","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}